Longleaf Partners, managed by Southeastern Asset Management, released its “Small-Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Longleaf experienced several environments throughout its experience in small-cap investing. This year, the underlying developments in the Fund’s holdings were more promising than the actual stock price returns when compared to the target of inflation plus 10% and the unusual performance of the Russell 2000. In Q4 2025, the Fund returned ...

分组1 - Alexander's reported quarterly funds from operations (FFO) of $2.43 per share, missing the Zacks Consensus Estimate of $3.02 per share, and down from $4.06 per share a year ago, representing an FFO surprise of -19.54% [1] - The company posted revenues of $53.26 million for the quarter, missing the Zacks Consensus Estimate by 0.27%, and down from $55.91 million year-over-year, having topped consensus revenue estimates only once in the last four quarters [2] - The stock has gained about 17% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] 分组2 - The future performance of Alexander's stock will depend on management's commentary during the earnings call and the company's FFO outlook, which includes current consensus FFO expectations for upcoming quarters [4] - The estimate revisions trend for Alexander's was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The current consensus FFO estimate for the upcoming quarter is $3.15 on revenues of $53.7 million, and for the current fiscal year, it is $12.52 on revenues of $216.4 million [7] 分组3 - The REIT and Equity Trust - Other industry, to which Alexander's belongs, is currently in the bottom 25% of the Zacks industry rankings, which may impact stock performance [8] - National Health Investors, another stock in the same industry, is expected to report quarterly earnings of $1.23 per share, reflecting a year-over-year change of +8.9%, with revenues expected to be $95.63 million, up 11.5% from the previous year [9][10]

Core Viewpoint - Alexander's reported quarterly funds from operations (FFO) of $4.06 per share, exceeding the Zacks Consensus Estimate of $3.57 per share, but down from $4.98 per share a year ago, indicating a 13.73% FFO surprise [1][2] Financial Performance - The company posted revenues of $54.92 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.94%, and down from $61.4 million year-over-year [2] - Over the last four quarters, Alexander's has surpassed consensus FFO estimates four times and topped consensus revenue estimates three times [2] Stock Performance - Alexander's shares have increased approximately 7.4% since the beginning of the year, contrasting with the S&P 500's decline of -3.3% [3] - The stock's immediate price movement will depend on management's commentary during the earnings call and future FFO expectations [3][4] Future Outlook - The current consensus FFO estimate for the upcoming quarter is $2.80 on $56 million in revenues, and for the current fiscal year, it is $11.50 on $223.8 million in revenues [7] - The estimate revisions trend for Alexander's is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The REIT and Equity Trust - Other industry is currently in the bottom 37% of over 250 Zacks industries, indicating potential challenges for stock performance [8]